Skip to content
Trial Eligibility
Menu

MoblO2 to Maintain Oxygenation

NCT07704567

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Many patients with chronic lung disease (e.g., chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD)) require supplemental oxygen (O2) at some point during their disease course.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • COPD (Chronic Obstructive Pulmonary Disease)
  • Intersitital Lung Disease

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
25 to 95 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Minnesota HealthSolutions
Last updated on ClinicalTrials.gov
July 22, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Colorado · 1

  • National Jewish Health · Denver, CO

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.